Details for New Drug Application (NDA): 211817
✉ Email this page to a colleague
NDA 211817 describes TESTOSTERONE CYPIONATE, which is a drug marketed by Am Regent, Cipla, Eugia Pharma, Hikma, Hikma Farmaceutica, Padagis Us, Rising, Sandoz, Sun Pharm Inds Ltd, Watson Labs, Watson Pharms Inc, Wilshire Pharms Inc, and Xiromed, and is included in fifteen NDAs. It is available from fifteen suppliers. Additional details are available on the TESTOSTERONE CYPIONATE profile page.
The generic ingredient in TESTOSTERONE CYPIONATE is estradiol cypionate; testosterone cypionate. There are seventy-five drug master file entries for this compound. Additional details are available on the estradiol cypionate; testosterone cypionate profile page.
The generic ingredient in TESTOSTERONE CYPIONATE is estradiol cypionate; testosterone cypionate. There are seventy-five drug master file entries for this compound. Additional details are available on the estradiol cypionate; testosterone cypionate profile page.
Summary for 211817
| Tradename: | TESTOSTERONE CYPIONATE |
| Applicant: | Eugia Pharma |
| Ingredient: | testosterone cypionate |
| Patents: | 0 |
Pharmacology for NDA: 211817
| Mechanism of Action | Androgen Receptor Agonists |
Suppliers and Packaging for NDA: 211817
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| TESTOSTERONE CYPIONATE | testosterone cypionate | INJECTABLE;INJECTION | 211817 | ANDA | Eugia US LLC | 55150-276 | 55150-276-01 | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-276-01) / 10 mL in 1 VIAL, MULTI-DOSE |
| TESTOSTERONE CYPIONATE | testosterone cypionate | INJECTABLE;INJECTION | 211817 | ANDA | Eugia US LLC | 55150-277 | 55150-277-01 | 1 VIAL, GLASS in 1 CARTON (55150-277-01) / 1 mL in 1 VIAL, GLASS |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 100MG/ML | ||||
| Approval Date: | Oct 20, 2023 | TE: | AO | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 200MG/ML | ||||
| Approval Date: | Oct 20, 2023 | TE: | AO | RLD: | No | ||||
Complete Access Available with Subscription
